Use Futu NiuNiu to view WUXI XDC (02268)'s stock price, real-time quotes, latest news, historical trend charts, financial information and quotes.
Websitehttps://wuxixdc.com/ More ▼ Peer analysis Key Information Key Information Stock Performance Per Share Data Efficiency Management Effectiveness Profitability Financial Strength Growth Rates CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash...
WUXI XDC Key Stats Markets News & Community About us Support Watchlist Screener Heat Map Institutional Tracker HK Stock MarketDetailed Quotes 02268 WUXI XDC Watchlist 31.850 +1.000+3.24% Market Closed Apr 17 16:08 CST 38.29BMarket Cap33.14P/E (TTM)...
Stock Price21.20 Revenue$0000 View About WuXi Biologics WuXi Biologics is a global open-access biologics technology platform specializing in the discovery, development, and manufacturing of biologics. The company provides end-to-end solutions for biologics drug development, from concept to commercial manu...
WXXWY Stock Price 1D 5D 1M 6M YTD 1Y 5Y 10Y MAX Basic Advanced +27.04% WuXi Biologics (Cayman) Inc. price and volume Combination chart with 2 data series. Chart represents WuXi Biologics (Cayman) Inc. price and volume over 1Y period The chart has 2 X axes displaying Time, and Time....
Equities 603259 CNE1000031K4 Biotechnology & Medical Research End-of-day quoteShanghai S.E. 2025-04-035-day change1st Jan Change 63.52CNY-3.83% -6.30%+15.41% Apr. 02WuXi AppTec Offloads 4.23% Stake in WuXi XDC CaymanMT Apr. 02WuXi AppTec Announces Disposal Of Certain Share Assets In WuX...
Hong Kong, Nov. 17, 2023 –WuXi Biologics (“WuXi Bio”) (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), congratulates its subsidiary WuXi XDC (stock code: 2268.HK), a leading global Contract Research,
Adjusted Non-IFRS[1] Net Profit Attributable to Owners of the Company Up 67.8% Year-Over-Year to RMB2,448 Million Adjusted Non-IFRS Diluted EPS Up 58.5% Year-Over-Year to RMB0.84[2] (SHANGHAI, August 12, 2021) — WuXi AppTec (stock code: 603259.SH / 2359.HK), a company that pr...
147.9 0.2 657.3 1.2 (77.5) Primarily due to bond conversions and fair value change along with the fluctuation of stock price during the Reporting Period. 440.5 0.7 324.1 0.6 35.9 Primarily due to increasing taxable temporary difference from long-term assets depreciation and biological assets fair ...
• No shareholders and management buyback despite weak share price suggests bearish long-term outlook • Company level buyback is not good enough Corporate Governance issue underestimated • WXB maintained original guidance until WuXi XDC HK IPO on 17 Nov 2023 and last minute guide down of 20...